Study to Evaluate the Safety and Clinical Activity of UCART123 in Patients With BPDCN

NCT03203369 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
1
Enrollment
INDUSTRY
Sponsor class

Stopped The trial was discontinued due to sponsor's decision and not a consequence of any safety concern.

Conditions

Interventions

Sponsor

Cellectis S.A.